Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro - PubMed (original) (raw)
doi: 10.1023/a:1006762425323.
F Zerimech, V Gouyer, R Lemaire, B Hemon, G Grard, C Thiebaut, V Lemaire, E Dacquembronne, T Duhem, A Lebrun, M J Dejonghe, G Huet
Affiliations
- PMID: 11235993
- DOI: 10.1023/a:1006762425323
Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro
M Balduyck et al. Clin Exp Metastasis. 2000.
Abstract
Several matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) were studied in highly invasive (MDA-MB-231) and slightly invasive (MCF-7, T47D, BT-20) breast cancer cell lines. Investigations were carried out at the protein level and/or at the mRNA level, either in cells cultured as monolayers on plastic, or in cells seeded on a thin layer of Matrigel basement membrane matrix. Analysis of MMP expression by RT-PCR showed expression of MMP-1. MMP-3, and MMP-13 in highly invasive MDA-MB-231 cells, but not in slightly invasive cell lines. The extracellular secretion of MMP-1 and MMP-3 by MDA-MB 231 cells could be also shown by ELISA. TIMP-1 and TIMP-2 mRNAs were found in all cell lines, however, the extracellular secretion of both TIMPs was much higher in MDA-MB-231 cells than in the other cell lines. When the cells were cultured on Matrigel matrix, MMP-9 expression was induced in MDA-MB-231 cells only, as assessed by RT-PCR and zymography experiments. The invasive potential of MDA-MB-231 cells evaluated in vitro through Matrigel was significantly inhibited by the MMP inhibitor BB-2516, by 25% and 50% at the concentrations of 2 x 10(-6) M and 10(-5) M, respectively. In conclusion, our data show that highly invasive MDA-MB-231 cells but not slightly invasive T47D, MCF-7 and BT-20 cells express MMP-1, MMP-3, MMP-9 and MMP-13. MMP-9 which is specifically up-regulated by cell contact to Matrigel, may play a key role in the invasiveness of MDA-MB-231 cells through basement membranes.
Similar articles
- Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC. Figueira RC, et al. BMC Cancer. 2009 Jan 14;9:20. doi: 10.1186/1471-2407-9-20. BMC Cancer. 2009. PMID: 19144199 Free PMC article. - Collagen induced MMP-2 activation in human breast cancer.
Thompson EW, Yu M, Bueno J, Jin L, Maiti SN, Palao-Marco FL, Pulyaeva H, Tamborlane JW, Tirgari R, Wapnir I, et al. Thompson EW, et al. Breast Cancer Res Treat. 1994;31(2-3):357-70. doi: 10.1007/BF00666168. Breast Cancer Res Treat. 1994. PMID: 7881112 Review. - Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM, Dickson RB, Hawkins MJ. Wojtowicz-Praga SM, et al. Invest New Drugs. 1997;15(1):61-75. doi: 10.1023/a:1005722729132. Invest New Drugs. 1997. PMID: 9195290 Review.
Cited by
- Biophysical interplay between extracellular matrix remodeling and hypoxia signaling in regulating cancer metastasis.
Lee SA, Cho GJ, Kim D, Kim DH. Lee SA, et al. Front Cell Dev Biol. 2024 Mar 13;12:1335636. doi: 10.3389/fcell.2024.1335636. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38544822 Free PMC article. Review. - Upregulation of Matrix Metalloproteinases in the Metastatic Cascade of Breast Cancer to the Brain.
Kamalabadi Farahani M, Atashi A, Bitaraf FS. Kamalabadi Farahani M, et al. Asian Pac J Cancer Prev. 2023 Sep 1;24(9):2997-3001. doi: 10.31557/APJCP.2023.24.9.2997. Asian Pac J Cancer Prev. 2023. PMID: 37774050 Free PMC article. - The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target.
Shibabaw T, Teferi B, Ayelign B. Shibabaw T, et al. Front Immunol. 2023 Mar 13;14:1094823. doi: 10.3389/fimmu.2023.1094823. eCollection 2023. Front Immunol. 2023. PMID: 36993955 Free PMC article. Review. - Laminin N-terminus α31 is upregulated in invasive ductal breast cancer and changes the mode of tumour invasion.
Troughton LD, O'Loughlin DA, Zech T, Hamill KJ. Troughton LD, et al. PLoS One. 2022 Mar 1;17(3):e0264430. doi: 10.1371/journal.pone.0264430. eCollection 2022. PLoS One. 2022. PMID: 35231053 Free PMC article. - The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets.
Kumar AA, Buckley BJ, Ranson M. Kumar AA, et al. Biomolecules. 2022 Jan 18;12(2):152. doi: 10.3390/biom12020152. Biomolecules. 2022. PMID: 35204653 Free PMC article. Review.
References
- Eur J Cancer. 1996 Nov;32A(12):2127-35 - PubMed
- Cancer Res. 1997 May 15;57(10):2055-60 - PubMed
- Hum Pathol. 1999 Apr;30(4):436-42 - PubMed
- Oncogene. 2000 Mar 16;19(12):1605-12 - PubMed
- Matrix Biol. 1998 Mar;16(8):483-96 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous